Scoop has an Ethical Paywall
Licence needed for work use Learn More
Parliament

Gordon Campbell | Parliament TV | Parliament Today | Video | Questions Of the Day | Search

 

Long time waiting for Dunne’s medicines strategy

Dr Jackie Blue
National Party Associate Health Spokeswoman (Pharmacare)

13 October 2006


Long time waiting for Dunne’s medicines strategy

Peter Dunne's promised review of medicines may have been a populist election platform in 2005 but the reality is it will be 2008 before the final report is available, says National's Associate Health spokeswoman (Pharmacare), Dr Jackie Blue.

She is commenting following Peter Dunne's address to the Multiple Sclerosis Society outlining the strategy.

"Here's hoping it isn't going to be a repeat of Labour's disastrous handling of the workforce crisis where, seven years, 40 reports and a plethora of committees and taskforces later, there's little to show.

"I am concerned that this review will be all puffery, no action and purely designed to get votes in 2008.

"The reality is that with the massive increase in registration and evaluation fees for new medicines, a hostile working environment for pharmaceutical companies which has seen ten major players downsize or exit in the past decade, and the increasing political uncertainty over the proposed joint trans-Tasman therapeutics agency, there is great reluctance to bring new medicines into New Zealand.

“Why would pharmaceutical companies bother to go through all this grief and financial uncertainty?

“That means the gap between New Zealand and Australia with regard to medicines access will continue to widen and Kiwis will miss out.”


ENDS

Advertisement - scroll to continue reading

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Parliament Headlines | Politics Headlines | Regional Headlines

 
 
 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 
 

InfoPages News Channels


 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.